NASDAQ
Botanix Pharmaceuticals Limited (BXPHF) has a price/sales ratio of 141.20x as of Friday, May 22, 2026. This represents a 103.26% increase compared to its 12-month average of 69.47x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.